BABA241018P65000
- 0.03
- 0.000.00%
Alibaba Newsroom
Barclays Maintains Alibaba(BABA.US) With Buy Rating, Maintains Target Price $137
Barclays Maintains Alibaba(BABA.US) With Buy Rating, Raises Target Price to $137
J.P. Morgan Maintains Alibaba(BABA.US) With Buy Rating, Raises Target Price to $125
BofA Securities Maintains Alibaba(BABA.US) With Buy Rating, Raises Target Price to $124
Morgan Stanley Maintains Alibaba(BABA.US) With Hold Rating, Raises Target Price to $115
Goldman Sachs Maintains Alibaba(BABA.US) With Buy Rating, Maintains Target Price $134
Macquarie Upgrades Alibaba(BABA.US) to Buy Rating, Raises Target Price to $145
Macquarie Upgrades Alibaba Group to Outperform From Neutral; Price Target Is HK$141
Macquarie Downgrades Alibaba Health Information Technology to Underperform From Neutral; Price Target Is HK$3.90
HSBC Maintains Alibaba(BABA.US) With Buy Rating, Raises Target Price to $134
Jefferies Maintains Alibaba(BABA.US) With Buy Rating, Raises Target Price to $142
Goldman Sachs Maintains Alibaba(BABA.US) With Buy Rating, Raises Target Price to $134
Citi Maintains Alibaba(BABA.US) With Buy Rating, Raises Target Price to $136
Alibaba Group Target Price Raised to HK$135.00 From HK$115.00 by Citi >9988.HK
Citi Maintains Alibaba(BABA.US) With Buy Rating, Maintains Target Price $116
BofA Securities Maintains Alibaba(BABA.US) With Buy Rating, Maintains Target Price $106
Citi Maintains Alibaba(BABA.US) With Buy Rating, Maintains Target Price $116
Morgan Stanley Maintains Alibaba(BABA.US) With Hold Rating, Maintains Target Price $90
The Zephirin Group Upgrades Alibaba Group to Hold From Sell, Adjusts Price Target to HK$91 From HK$74
Jefferies Maintains Alibaba(BABA.US) With Buy Rating, Maintains Target Price $116